Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.
What is Spyre Therapeutics's quote symbol?
What is the 52 week high and low for Spyre Therapeutics (NASDAQ: SYRE)?
How much is Spyre Therapeutics stock worth today?
How much is Spyre Therapeutics's stock price per share?
What is Spyre Therapeutics's Market Cap?